Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer

Thumbnail Image

Files

Integrating Apparent_2026.pdf (1.01 MB)
Identifiers
URI: https://hdl.handle.net/11268/16823
DOI: 10.3390/biomedicines13081979

Publication date

2025

Authors

Fernández, Julio
López Campos, Fernando

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

This study evaluates the combined prognostic value of the apparent diffusion coefficient (ADC) from multiparametric MRI (mpMRI) and prostate-specific antigen (PSA) levels at 6 months post-radiotherapy (RT) in assessing treatment response in prostate cancer patients treated with RT and androgen deprivation therapy (ADT).

Description

UNESCO Subjects

Cáncer
Investigación médica
Tratamiento médico

Keywords

Bibliographic reference

Duque-Santana, V., Fernandez, J., López-Campos, F., Diaz-Gavela, A., Recio, M., Guerrero, L. L., Peña, M., Sanchez, S., Thuissard, I. J., Andreu-Vázquez, C., Sanz-Rosa, D., Marvaso, G., Gómez-Iturriaga, A., Zilli, T., Del Cerro, E., & Couñago, F. (2025). Integrating apparent diffusion coefficient and prostate-specific antigen as prognostic factors of treatment response to androgen deprivation therapy and radiotherapy in prostate cancer. Biomedicines, 13(8), 1979. https://doi.org/10.3390/biomedicines13081979
Editor's version
https://doi.org/10.3390/biomedicines13081979

Type of document

journal article

Collections

Área de Biomedicina Clásica
Attribution 4.0 International

La licencia de este ítem se describe como Attribution 4.0 International